Recombinant R. sanguineus Evasin-3 His-tag Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 10034-EV
Key Product Details
- R&D Systems Sf 21 (baculovirus)-derived Recombinant R. sanguineus Evasin-3 His-tag Protein (10034-EV)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Product Specifications
Source
Leu21-Arg86. with a C-terminal 6-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The ED50 for this effect is 0.15-0.9 μg/mL.
Scientific Data Images for Recombinant R. sanguineus Evasin-3 His-tag Protein, CF
Recombinant R. sanguineus Evasin-3 His-tag Protein Bioactivity
Recombinant R. sanguineus Evasin-3 (Catalog # 10034-EV) inhibits IL-8/CXCL8-induced chemotaxis of BaF3 mouse pro‑B cells transfected with human CCXR2. The ED50 for this effect is 0.15-0.9 μg/mL.Formulation, Preparation and Storage
10034-EV
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 250 μg/mL in PBS. |
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Evasin-3
Evasin-3 is a highly selective chemokine-binding protein isolated from tick saliva. The cDNA of tick Evasin-3 encodes an 86 amino acid (aa) precursor, which includes a 20 aa signal peptide and a 66 aa mature protein (1). Ticks are blood sucking parasites that secrete a wide variety of immunomodulatory proteins to evade the host immune response. The saliva isolated from Ticks has shown to contain chemokine neutralization activity. These proteins have been identified as chemokine binding proteins (CHPBs) that were termed as Evasins (1,2.3). Evasin-3 belongs to a new class of chemokine binding proteins in that it shows high affinity binding to a very limited set of chemokines, including CXCL8 and CXCL1. Since it is very small molecule Evasin-3 may be therapeutically useful as novel anti-inflammatory agent.
References
- Frauenschuh, A. et al. (2007) J. Biol. Chem. 282:27250.
- Deruaz, M. et al. (2008) J. Exp. Med. 205:2019.
- Deruaz, M. et al. (2013) FEBS J. 280:4876.
Long Name
UniProt
Additional Evasin-3 Products
Product Documents for Recombinant R. sanguineus Evasin-3 His-tag Protein, CF
Product Specific Notices for Recombinant R. sanguineus Evasin-3 His-tag Protein, CF
For research use only